Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: A case–control study
doi: 10.1002/bdra.23348
pmid: 25656965
Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: A case–control study
BackgroundEpigenetic changes leading to improper methylation of the pericentromeric region of chromosome 21 may contribute to the nondisjunction of this chromosome. Polymorphisms in the DNA Methyltransferase 3B (DNMT3B) gene, one of the crucial gene of the folate metabolism, affects the activity of the enzyme and increases the susceptibility of nondisjunction in mothers of Down syndrome children (MDS).MethodsConsidering this hypothesis we investigated the association of single nucleotide polymorphisms in the promoter region of the DNMT3B gene (rs1569686 ‐579G>T; rs2424913 ‐149C>T) with a predisposition of mothers to deliver a Down syndrome (DS) child. The study was performed on DNA samples from 150 MDS and 172 control mothers. Transmission disequilibrium tests were performed on 103 DS trio families. Genotyping was done using a polymerase chain reaction‐restriction fragment length polymorphism method.ResultsWith respect to the single nucleotide polymorphisms studied, no significant difference was observed in the genotypes and alleles frequency distributions between MDS and control mothers. The frequency of the DNMT3B‐579G allele was, respectively, 0.34 in MDS and 0.33 in control mothers whereas the frequency of the DNMT3B‐149C allele was respectively 0.31 in MDS and 0.26 in control mothers. No significant deviation in genotypic combinations as well as in transmission disequilibrium tests analysis was observed. However, a strong linkage disequilibrium was observed with significant differences in the distribution of G‐T and G‐C haplotypes among case and control mothers.ConclusionAlthough the above studied polymorphisms of DNMT3B may not be an independent risk factor it might be possible that certain allelic combinations (G‐T) are. This finding suggests that DNMT3B might be a maternal risk factor for DS in our Indian cohort. Replication studies are required to confirm these findings. Birth Defects Research (Part A) 103:299–305, 2015. © 2015 Wiley Periodicals, Inc.
DNA Methyltransferase 3B, Genotype, India, Polymorphism, Single Nucleotide, Risk Assessment, Gene Frequency, Nondisjunction, Genetic, Humans, Female, DNA (Cytosine-5-)-Methyltransferases, Down Syndrome, Promoter Regions, Genetic
DNA Methyltransferase 3B, Genotype, India, Polymorphism, Single Nucleotide, Risk Assessment, Gene Frequency, Nondisjunction, Genetic, Humans, Female, DNA (Cytosine-5-)-Methyltransferases, Down Syndrome, Promoter Regions, Genetic
11 Research products, page 1 of 2
- 2013IsAmongTopNSimilarDocuments
- 2008IsAmongTopNSimilarDocuments
- 2013IsAmongTopNSimilarDocuments
- 2017IsRelatedTo
- 2017IsRelatedTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).12 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
